Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
This observational study examined 103 women who recently completed early-stage breast cancer treatment, finding that over 60% experienced fatigue and sleep disturbances, and 25% showed elevated depressive symptoms. Chemotherapy was associated with higher levels of fatigue, sleep problems, depressive symptoms, and increased levels of the inflammatory marker sTNF-RII (all P